by Robert Sheard (MF DowMan) LEXINGTON, Ky. (May 10): *****IFG ANNOUNCEMENT ***** This weekend's Investing For Growth updates (both the current stock list and the two weekly files in the IFG Statistics Center) will be delayed, probably until Sunday afternoon. Value Line's weekly edition didn't arrive in today's mail unfortunately. And I'll be online precious little tomorrow as I take the day to spend with my family on my wife's and my wedding anniversary. So look for the updated information sometime Sunday afternoon (maybe earlier, but don't flame me if it's not). Today was another strong day for Investing For Growth in the absence of a lot of news. The one exception to that, however, was good news for IFG cellar-dweller Medtronic <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:MDT)") else Response.Write("(NYSE:MDT)") end if %>. The company received marketing approval today from the U.S. Food and Drug Administration for its Jewel Plus Active Can implantable cardioverter-defibrillator, a device used to treat abnormal heartbeats. Medtronic also received approval to market its Transvene tined silicone lead in the United States. The product is the world's first tachyarrhythmia lead which uses a certain electrode that minimizes scar-tissue formation. The Street liked the news and pushed shares of Medtronic up more than 6% on the day, dragging it out of the cellar and firmly into ... ahem ... ninth place. In Relative Strength Model news, Mirage Resorts' <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:MIR)") else Response.Write("(NYSE:MIR)") end if %> corporate credit was upgraded by Standard & Poor's from triple-B to triple-B-plus. And following yesterday's stellar same-store sales report, The Gap <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:GPS)") else Response.Write("(NYSE:GPS)") end if %> was rewarded today with an upgrade at Morgan Stanley from Outperform to Strong Buy. You gotta hand it to the guys on this call in their Fool Portfolio. Cash-strong Gap fought off an ugly period for retail in general and bounced back wonderfully. Many readers thought the Fools were way too early on this stock (myself among them at the time), but the results are in their portfolio returns. I doff my belled-cap to them on this one! The Relative Strength models also fared well today, with the Quarterly Variation picking up 2.8% on the day. Have a great weekend, Fools! Transmitted: 5/10/96 | ||||||||
| ||||||||
| ||||||||